Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

Citations Over TimeTop 1% of 2005 papers

Abstract

Drug-resistant variants are frequently present in both recently and chronically infected therapy-naive patients. Drug-resistant variants are most commonly seen in patients infected with subtype B virus, probably because of longer exposure of these viruses to drugs. However, an increase in baseline resistance in non-B viruses is observed. These data argue for testing all drug-naive patients and are of relevance when guidelines for management of postexposure prophylaxis and first-line therapy are updated.

Related Papers

• → Surveillance of HIV-1 drug resistance in Xinjiang: high prevalence of K103N in treatment-naïve individuals(2018)15 cited
• → HIV type 1 drug resistance patterns among patients failing first and second line antiretroviral therapy in Nairobi, Kenya(2014)12 cited
• → A decade of viral mutations and associated drug resistance in a population of HIV-1+ Puerto Ricans: 2002–2011(2017)4 cited
• → Evolvement of HIV-1 drug resistant mutations in vitro without drug pressure(2010)2 cited
• Analysis on drug resistance of human immunodeficiency virus by means of gene detection(2012)